AstrazenecaAZN
13F holders, Q3 2024 (September 30)4holders
1new positions
1sold out
$163.96avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, unchanged from Q2 2024. 1 opened new positions and 1 sold out. The largest holders were Boston Common Asset Management, LLC ($40.8M), FNY Investment Advisers, LLC ($2.3M) and Eagle Bay Advisors LLC ($156K).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $156K |
| Exits | 1 | $10.0M |
All 13F filers, Q2 2024 → Q3 2024: 1,001 shares bought and 90,763 shares sold, net −89,762 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Boston Common Asset Management, LLC | 1.06% | Reduce -9.2% | 262,273 | $40.8M |
| FNY Investment Advisers, LLC | 1.13% | No change | 200 | $2.3M |
| Eagle Bay Advisors LLC | 0.06% | New | 1,001 | $156K |
| Raffa Wealth Management, LLC | 0.01% | No change | 464 | $36K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.